Novartis AGNVSNYSE
Loading
Price to Sales HistoryNormalizing
Percentile Rank100
3Y CAGR+1.1%
5Y CAGR+1.7%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
+1.1%/yr
vs +4.5%/yr prior
5Y CAGR
+1.7%/yr
Consistent
Acceleration
-3.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthNormalizing
PeriodValueYoY Change
20254.69+23.1%
20243.81-15.7%
20234.52-0.4%
20224.54+1.1%
20214.49+4.1%
20204.31-3.4%
20194.47+17.4%
20183.80-5.7%
20174.03+30.5%
20163.09-